AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

This week ended up as a pretty active one for large startup financings. AI and biotech were the biggest areas for funding, ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Despite the long holiday weekend, news in biopharma never slows down. | This week on "The Top Line," we break down ...

Instead, Stealth submitted a new drug application seeking approval of elamipretide, and the FDA issued its refusal-to-file ...

A therapy at the center of their $22 billion alliance failed to extend survival in a type of lung tumor, leading the ...

After Merck paid a hefty sum to co-develop and co-commercialize HER3-DXd, the drug has suffered notable setbacks in ...

10x Genomics, 93 job cuts in Pleasanton. The biotech company plans to complete the staffing reductions by July 7. — Chevron, 65 staffing reductions in Richmond. The downsizing is scheduled for ...

Novo Nordisk is teaming up with U.S. biotech Septerna to create a new obesity pill Septerna could receive up to $2.2 billion in funding The goal is to develop pills that target special proteins in ...

Novo Nordisk will pay all the research and development costs for the project. The U.S. biotech company has developed a platform that finds and develops drugs that target special proteins called G ...

Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to ...